Home › NDC Lookup › RxCUI directory › RxCUI 1432261

Acetaminophen 300 MG / butalbital 50 MG / caffeine 40 MG Oral Capsule [Fioricet] — RxCUI 1432261

RxNorm drug concept · Semantic branded drug
RxCUI 1432261 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1432261
Official nameAcetaminophen 300 MG / butalbital 50 MG / caffeine 40 MG Oral Capsule [Fioricet]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asAPAP 300 MG / butalbital 50 MG / Caffeine 40 MG Oral Capsule [Fioricet]; Fioricet 50 MG / 300 MG / 40 MG Oral Capsule
FDA products mapped1
Package NDCs mapped1
Reported Medicaid activity (SDUD)148 prescriptions · 2 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Acetaminophen, Butalbital, and Caffeine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Yes, that's exactly what it's intended for. This combination of butalbital, acetaminophen, and caffeine is prescribed specifically to relieve tension headaches — the kind caused by...
  • What exactly is this medication for? My doctor prescribed it for headaches — is that normal?
  • This is actually something to be careful about. Butalbital, one of the ingredients, is habit-forming — meaning your body can become physically dependent on it if you take it freque...
  • Can I take this regularly if I get headaches a lot?
📖 Read our full Acetaminophen, Butalbital, and Caffeine guide →

🕸️ Concept Web — How Acetaminophen 300 MG / butalbital 50 MG / caffei... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Acetaminophen 300 MG / butalbital 50 MG / caffeine 40 MG Oral Capsule [Fioricet] RxCUI 1432261

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 4

    The active substance itself — no strength, form, or brand attached yet.

    • Acetaminophen 161
    • Butalbital 19860
    • Caffeine 1886
    • Acetaminophen / butalbital / caffeine 214130
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Fioricet 175184
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Acetaminophen / butalbital / caffeine Oral Capsule 374750
    • Acetaminophen / butalbital / caffeine Oral Product 1152255
    • Acetaminophen / butalbital / caffeine Pill 1152256
    • Acetaminophen / butalbital / caffeine Oral Capsule [Fioricet] 1432260
    • Fioricet Oral Product 1168322
    • Fioricet Pill 1168323
    • Oral Capsule 316965
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 5

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 18 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Acetaminophen 300 MG / butalbital 50 MG / caffeine 40 MG Oral Capsule SCD · 889520
  • Acetaminophen 300 MG SCDC · 315261
  • Butalbital 50 MG SCDC · 317309
  • Caffeine 40 MG SCDC · 317310
  • Acetaminophen / butalbital / caffeine Oral Capsule SCDF · 374750
  • Acetaminophen / butalbital / caffeine Oral Product SCDG · 1152255
  • Acetaminophen / butalbital / caffeine Pill SCDG · 1152256

Brand-Name Concepts

  • Acetaminophen 300 MG / butalbital 50 MG / caffeine 40 MG [Fioricet] SBDC · 1432259
  • Acetaminophen / butalbital / caffeine Oral Capsule [Fioricet] SBDF · 1432260
  • Fioricet Oral Product SBDG · 1168322
  • Fioricet Pill SBDG · 1168323
  • Fioricet BN · 175184

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 1432261 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
52544-0080-01 100 CAPSULE in 1 BOTTLE (52544-080-01) Fioricet Actavis Pharma, Inc. 2013-07-29
Observed labelers: Actavis Pharma, Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ea · median
$8.8237
Range $8.8237–$8.8237 · middle 50% $8.8237–$8.8237 · 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.